Загрузка...
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective
INTRODUCTION: Evidence-based clinical data on coronavirus disease 2019 (COVID-19) pharmacotherapies are scarce. OBJECTIVE: This study documented and characterized COVID-19 cases reported in individuals receiving treatment with Pfizer pharmaceutical products and cases that reported use of Pfizer phar...
Сохранить в:
| Опубликовано в: : | Drug Saf |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7755229/ https://ncbi.nlm.nih.gov/pubmed/33354753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-020-01035-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|